Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen (Q33488970)
scientific article published on June 1, 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen |
scientific article published on June 1, 1995 |
Statements
1 reference
Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen (English)
1 reference
Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen (English)
J. Atzpodien
E. Lopez Hänninen
H. Kirchner
A. Franzke
A. Körfer
M. Volkenandt
S. Duensing
A. Schomburg
S. Chaitchik
1 June 1995
1 reference
1 reference
31A
1 reference
876-881
1 reference
Identifiers
1 reference
1 reference